SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-217430
Filing Date
2022-08-10
Accepted
2022-08-10 16:46:33
Documents
13
Period of Report
2022-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d281159d8k.htm   iXBRL 8-K 31125
2 EX-10.1 d281159dex101.htm EX-10.1 365628
  Complete submission text file 0001193125-22-217430.txt   621223

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20220808.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20220808_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20220808_pre.xml EX-101.PRE 11263
7 EXTRACTED XBRL INSTANCE DOCUMENT d281159d8k_htm.xml XML 3460
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 221152421
SIC: 2834 Pharmaceutical Preparations